Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial.

D. Preiss, L. Thomas, J. Sun, S.M. Haffner, R.R. Holman, E. Standl, L.A. Leiter, T. Mazzone, G.E.H.M. Rutten, G. Tognoni, F.A. Martinez, F.T. Chiang, R.M. Califf, J.J. McMurray

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)e001925
Number of pages1
JournalBMJ open [E]
Volume2
Issue number6
Publication statusPublished - 2012

Cite this